Schedule 13G ownership disclosure

CURE PHARMA HOLDING CORP COM

Common Stock, par value $0.001 per share · CUSIP: 23127P104

Event date: 2024-11-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ionic Ventures, LLC

    Shares: 8,306,000.00 · Class: 9.5%

  • Ionic Management, LLC

    Shares: 8,306,000.00 · Class: 9.5%

  • Brendan O'Neil

    Shares: 8,306,000.00 · Class: 9.5%

  • Keith Coulston

    Shares: 8,306,000.00 · Class: 9.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-000072
Form type
SCHEDULE 13G
Filer
Avenir Wellness Solutions, Inc.
CIK
CIK 1643301
Filed
Jan 10, 2025
Reporting period
Nov 07, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub